DIRECT study: a commentary

Chaturvedi, N. , Porta, M. , Klein, R. , Orchard, T. , Fuller, J. , Parving, H.H. , et al. (2008) Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet 372: 1394-402.

Sjolie, A.K. , Klein, R. , Porta, M. , Orchard, T. , Fuller, J. , Parving, H.H. , et al. (2008) Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet 372: 1385-93.

Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287: 2563-9.

Kohner, E.M. (2008) Microvascular disease: what does the UKPDS tell us about diabetic retinopathy? Diabet Med 25(suppl 2): 20-4.

Gaede, P. , Lund-Andersen, H. , Parving, H.H. , Pedersen, O. ( 2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358: 580-91.

Suzuma, I. , Hata, Y. , Clermont, A. , Pokras, F. , Rook, S.L. , Suzuma, K. , et al. (2001) Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 50: 444-54.

Moravski, C.J. , Kelly, D.J. , Cooper, M.E. , Gilbert, R.E. , Bertram, J.F. , Shahinfar, S. , et al. (2000) Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension 36: 1099-104.

Zhang, X. , Lassila, M. , Cooper, M.E. , Cao, Z. ( 2004) Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors. Hypertension 43: 276-81.

Chaturvedi, N. , Sjolie, A.K. , Stephenson, J.M. , Abrahamian, H. , Keipes, M. , Castellarin, A. , et al. (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURO-DIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351: 28-31.

Mauer M. , Zinman B. , Gardiner R. , Suissa S. , Sinaiko A. , Strand T. , Drummond K. , et al. (2009) Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes. New England Journal of Medicine 361: 40-51.

Patel, A. , MacMahon, S. , Chalmers, J. , Neal, B. , Woodward, M. , Billot, L. , et al. (2007) Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial . Lancet 370: 829-40.